Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Cohu
COHU
$2.26B
| $754K | ﹤0.01% |
21,898
-15,230
| -41% | -$573K |
|
2652
Stepan Co
SCL
$1.46B
| $753K | ﹤0.01% |
10,046
-6,286
| -38% | -$550K |
|
2653
Hilton Grand Vacations
HGV
$3.59B
| $752K | ﹤0.01% |
18,467
-26,518
| -59% | -$1.17M |
|
2654
Western Midstream Partners
WES
$19.2B
| $752K | ﹤0.01% |
27,599
-61,290
| -69% | -$1.66M |
|
2655
CALL
Toast
TOST
$18.7B
| $749K | ﹤0.01% |
+40,000
| New | +$868K |
|
2656
St. Joe Company
JOE
$3.54B
| $749K | ﹤0.01% |
13,788
-12,656
| -48% | -$731K |
|
2657
CALL
BridgeBio Pharma
BBIO
$15.7B
| $749K | ﹤0.01% |
28,400
+5,700
| +25% | +$162K |
|
|
2658
PUT
BridgeBio Pharma
BBIO
$15.7B
| $749K | ﹤0.01% |
+28,400
| New | +$806K |
|
2659
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.62B
| $749K | ﹤0.01% |
29,191
-847
| -3% | -$22.3K |
|
|
SWAV
2660
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $748K | ﹤0.01% |
3,758
-14,980
| -80% | -$3.54M |
|
|
SLRN
2661
DELISTED
ACELYRIN
SLRN
| $745K | ﹤0.01% |
+73,269
| New | +$1.56M |
|
2662
Banc of California
BANC
$3.03B
| $744K | ﹤0.01% |
60,118
-39,590
| -40% | -$504K |
|
2663
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.09B
| $744K | ﹤0.01% |
31,242
-10,032
| -24% | -$248K |
|
2664
Conduent
CNDT
$244M
| $744K | ﹤0.01% |
213,716
-62,298
| -23% | -$208K |
|
2665
CALL
Arcturus Therapeutics
ARCT
$164M
| $741K | ﹤0.01% |
+29,000
| New | +$893K |
|
|
2666
PUT
Arcturus Therapeutics
ARCT
$164M
| $741K | ﹤0.01% |
+29,000
| New | +$893K |
|
2667
Preferred Bank
PFBC
$1.24B
| $739K | ﹤0.01% |
11,874
-10,345
| -47% | -$646K |
|
|
BBT
2668
Beacon Financial Corp
BBT
$2.66B
| $739K | ﹤0.01% |
36,854
-33,666
| -48% | -$721K |
|
2669
B2Gold
BTG
$5B
| $739K | ﹤0.01% |
256,033
+190,993
| +294% | +$622K |
|
2670
Citi Trends
CTRN
$555M
| $737K | ﹤0.01% |
33,181
+33,126
| +60,229% | +$677K |
|
|
DOC
2671
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $736K | ﹤0.01% |
60,412
-50,365
| -45% | -$696K |
|
2672
Concentrix
CNXC
$1.5B
| $736K | ﹤0.01% |
9,192
+3,139
| +52% | +$246K |
|
2673
CorVel
CRVL
$3.06B
| $735K | ﹤0.01% |
11,217
-14,271
| -56% | -$984K |
|
2674
ICU Medical
ICUI
$4.21B
| $735K | ﹤0.01% |
6,173
+4,835
| +361% | +$721K |
|
2675
CALL
Madrigal Pharmaceuticals
MDGL
$10.8B
| $730K | ﹤0.01% |
5,000
+4,500
| +900% | +$847K |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.